Selected article for: "report case and secondary case"

Author: Norton, Emma J; Sheikh, Nadim
Title: Splenic Infarct Due to a Patent Foramen Ovale and Paradoxical Emboli Post-COVID-19 Infection: A Case Study
  • Cord-id: a1wkys2r
  • Document date: 2021_5_7
  • ID: a1wkys2r
    Snippet: Hypercoagulability is now a recognized complication of COVID-19 infection. Despite this, splenic infarction remains rare and is often found incidentally, radiologically, or at autopsy. We report a case of symptomatic splenic infarction with superimposed infection, secondary to COVID-19-induced hypercoagulability in a young patient with paradoxical emboli due to an undiagnosed patent foramen ovale (PFO). This multifactorial case should prompt a level of suspicion of the patient with unexplained a
    Document: Hypercoagulability is now a recognized complication of COVID-19 infection. Despite this, splenic infarction remains rare and is often found incidentally, radiologically, or at autopsy. We report a case of symptomatic splenic infarction with superimposed infection, secondary to COVID-19-induced hypercoagulability in a young patient with paradoxical emboli due to an undiagnosed patent foramen ovale (PFO). This multifactorial case should prompt a level of suspicion of the patient with unexplained abdominal pain and recent COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and admission prior: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and lupus anticoagulant: 1, 2
    • abdominal pain vomiting and admission prior: 1, 2, 3, 4
    • abdominal pain vomiting and low molecular weight heparin: 1
    • abdominal pain vomiting and lupus anticoagulant: 1
    • abdominal pain vomiting nausea and admission prior: 1
    • admission prior and low molecular weight heparin: 1, 2
    • admission prior and lupus anticoagulant: 1, 2
    • low molecular weight heparin and lupus anticoagulant: 1, 2, 3, 4, 5